Abstract:Although there are international guidelines on management of antithrombotics (anti-platelet agents and anticoagulants) in patients undergoing colonoscopic polypectomy, both clinicians’ adherence to guidelines and patients’ compliance to clinicians’ instructions are largely unknown. We previously reported in a retrospective study that less than 15% of clinicians documented their peri-endoscopy instructions on anti-thrombotic use. We aim to investigate prospectively clinician’s adherence to international guideline and patients’ compliance to clinicians’ instructions on peri-endoscopic management of antithrombotics. The Colonoscopy Registry was established in November 2017. It collects prospective data from patients on antithrombotics use undergoing elective colonoscopies in a tertiary referral center in Hong Kong. Demographic data, types and indications of antithrombotics, peri-endoscopic management, colonoscopic findings, 7-day and 6-month follow-up for resumption of antithrombotics, post-polypectomy bleeding and serious cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, or death from a vascular cause) were collected. Peri-endoscopic management of antithrombotics is defined as thoroughly adherent to the guidelines developed by Asian Pacific Association of Gastroenterology and Asian Pacific Society for Digestive Endoscopy when all conditions are fulfilled: correct decision of withholding/resuming drug, appropriate drug discontinuation, INR <2.0 before colonoscopic polypectomy and appropriate use of bridging therapy in patients on warfarin. Patient’s compliance to clinicians’ instructions is defined whether the use of antithrombotics during the peri-endoscopy period is consistent with clinicians’ advice. Doctors’ adherence was captured from casenotes while patient’s compliance to clinicians’ instructions were collected at face-to-face interview. From November 2017 to September 2019, 610 patients receiving antithrombotics with colonoscopic polypectomy were recruited. One hundred percent, 41.2%, 71.4% of clinicians adhered to the guidelines for aspirin alone, clopidogrel alone, and dual antiplatelet therapy (DAPT), respectively. As for warfarin and direct oral anti-coagulant (DOAC), 10.2% and 41.1% of clinicians respectively has full adherence. Regarding patients’ compliance, 75.3%, 41.2% ,85.7%, 38.8% and 36.8% were compliant in aspirin-alone, clopidogrel alone, DAPT, warfarin, and DOAC, respectively. Twenty patients (3.3%) developed immediate polypectomy bleeding,17 patients (2.8%) had delayed polypectomy bleeding, and 7 had serious cardiovascular events within 6-months of colonoscopy. Both clinicians’ adherence to guidelines and patient’s compliance to instructions on clopidogrel and anticoagulant use were sub-optimal. More emphasis should be put to it.

Su1636 Risk of Post Colonoscopic Polypectomy Bleeding in Patients on New Oral Anti-Coagulant and a Case Control Study

Risk Analysis of New Oral Anticoagulants for Gastrointestinal Bleeding and Intracranial Hemorrhage in Atrial Fibrillation Patients: a Systematic Review and Network Meta-Analysis

Su1683 Concurrent Anti-Thrombotic and Anti-Coagulation Use Predict Severe Bleeding in Colorectal Endoscopic Submucosal Dissection

Impact of Physicians’ and Patients’ Compliance on Outcomes of Colonoscopic Polypectomy With Anti-Thrombotic Therapy

Risk of Postpolypectomy Bleeding with Uninterrupted Clopidogrel Therapy in an Industry-Independent, Double-Blind, Randomized Trial.

Clinicians' Adherence And Patients' Compliance To Guidelines For The Management Of Antithrombotics In Patients Undergoing Colonoscopic Polypectomy

Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management

Interruption Of Anti-Thrombotic Therapies And Risk Of Post-Colonoscopy Thromboembolic Events: A Real-World Cohort Study

Bleeding Risks with Novel Oral Anticoagulants During Catheter Ablation of Atrial Fibrillation: a Systematic Review and Network Meta-Analysis.

Safety and Effectiveness of Direct Oral Anticoagulants vs. Warfarin in Patients With Atrial Fibrillation and Endoscopy-Diagnosed Peptic Ulcer

Risks of bleeding and thromboembolic events in patients undergoing colonoscopy on uninterrupted and interrupted anticoagulant therapy in real-world setting

[Perioperative management of patients on NOACs]

Risk of spontaneous intracerebral hemorrhage associated with NOACs compared with aspirin and warfarin: A long-term single hospital follow-up study

Prevention of Gastrointestinal Events in Patients on Antithrombotic Therapy in the Peri‐endoscopy Period: Review of New Evidence and Recommendations from Recent Guidelines

Bleeding and thromboembolic risk in patients under anticoagulant therapy receiving oral surgery: a systematic review

116 Early and Late Resumption of Aspirin after Endoscopic Therapy for Bleeding Peptic Ulcers - A Cohort Study

Advances in clinical studies of oral anticoagulation

New Oral Anticoagulants: How Do We Use Them Wisely?

Effectiveness of Prophylactic Clipping in Preventing Postpolypectomy Bleeding in Aspirin Users: a Propensity-Score Analysis

Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence

CLINICIAN INSTRUCTIONS ON MANAGEMENT OF ANTITHROMBOTICS BEFORE COLONOSCOPY: A RETROSPECTIVE ANALYSIS OF 4,777 PATIENTS IN ONE YEAR COHORT